Industry News
-
JPM25: Deals, Summit’s bravado and gene therapy headwinds
Jan 13 2025 -
Bayer’s BlueRock now plans to bring Parkinson’s cell therapy straight to Phase 3 trial
Jan 13 2025 -
Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson’s Disease
Jan 13 2025 -
AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
Jan 13 2025 -
Exclusive: Bucking gene editing downturn, Tune raises $175M to bring epigenetic editing to clinic
Jan 12 2025 -
[1/10/2025] Gene and Cell Therapy- weekly digest from PackGene
Jan 10 2025 -
Intellia to stop work on rare disease therapy, lay off staff
Jan 10 2025 -
A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours
Jan 10 2025 -
Verismo Therapeutics Announces First Patient Infused in Phase 1 CELESTIAL-301 Clinical Trial of SynKIR™-310
Jan 10 2025